News blog

Tristel

  • BY: Andrew Hore |
  • POSTED: 31/10/2011 |

Tristel’s figures for the year to June 2011 were in line with the downgraded expectations but there are positive signs for international sales this year. 

The infection and contamination control products supplier had already warned that the costs of investing in launching products for the personal care sector and delays in gaining regulatory approval in China and Germany would drag down profit, especially as revenues were slower than expected in coming through.

There were some initial sales of Crystel non sterile products to cosmetics and toiletries manufacturers but they only contributed £38,000 of the revenues of £9.29m, up from £8.76m the year before.

Overseas sales rose from £747,000 to £1m. Sales in China were £78,000 and these are expected to rise to £600,000 this year, while German sales are forecast to improve from £50,000 to £300,000. No further regulatory approvals are required for these sales to be achieved. This means that Tristel is on course to double overseas sales this year. This will offset falling revenues from cleaning products for endoscopes in hospitals.

Last year’s underlying profit slumped from £1.5m to £500,000. Analysts forecast a recovery in profit to £1m. 

Tristel had net cash of £325,000 at the end of June 2011.

At 39.5p a share, Tristel is valued at £15.8m.

Download the latest AIM Journal from http://www.hubinvest.com/AIMPDFOctober2011_25.pdf

© 2024 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds